The optimal duration of dual antithrombotic therapy after percutaneous coronary intervention (PCI) in patients with atrial fibrillation remains uncertain.
A recent study compared the efficacy and safety of 1-month versus 12-month dual antithrombotic therapy in this population: spkl.io/60107KhTK